Samsung Bioepis
Sandoz to market Samsung Bioepisâ biosimilar of Stelara in US and Canada
Anika Sharma
Sandoz is expanding its biosimilar portfolio by signing a commercialization agreement with Samsung Bioepis for a biosimilar version of Johnson ...
Is Biogen giving up its biosims business to Samsung Bioepis?
SG Tylor
During the first-quarter earnings call, CEO Chris Viehbacher discussed his plan to revitalize Biogen and emphasized the need to find ...
